[Form 4] Qualys, Inc. Insider Trading Activity
Qualys, Inc. Chief Financial Officer Joo Mi Kim sold a total of 844 shares of Qualys common stock on 09/05/2025 under a pre-established Rule 10b5-1 trading plan adopted August 21, 2024. The three sale transactions show weighted average sale prices in ranges from $133.68 to $136.45 per share and resulted in reported beneficial ownership of 93,651 shares following the transactions. The filing also discloses an exempt purchase of 27 shares on August 15, 2025 through the company’s Employee Stock Purchase Plan. The Form 4 was signed by power of attorney on September 8, 2025.
Joo Mi Kim, Chief Financial Officer di Qualys, Inc., ha venduto complessivamente 844 azioni ordinarie di Qualys il 09/05/2025 nell'ambito di un piano di trading predefinito ai sensi della Rule 10b5-1 adottato il 21 agosto 2024. Le tre operazioni di vendita riportano prezzi medi ponderati per azione compresi tra $133.68 e $136.45 e hanno determinato una partecipazione beneficiaria dichiarata di 93.651 azioni a seguito delle transazioni. Il deposito segnala inoltre un acquisto esente di 27 azioni il 15 agosto 2025 attraverso il Piano di Acquisto Azioni per i Dipendenti della società. Il Modulo 4 è stato firmato per procura il 8 settembre 2025.
Joo Mi Kim, directora financiera (Chief Financial Officer) de Qualys, Inc., vendió un total de 844 acciones ordinarias de Qualys el 09/05/2025 bajo un plan de negociación preestablecido conforme a la Rule 10b5-1 adoptado el 21 de agosto de 2024. Las tres transacciones de venta muestran precios medios ponderados por acción en un rango de $133.68 a $136.45 y dieron lugar a una tenencia beneficiaria declarada de 93.651 acciones tras las operaciones. La presentación también revela una compra exenta de 27 acciones el 15 de agosto de 2025 a través del Plan de Compra de Acciones para Empleados de la compañía. El Formulario 4 fue firmado por poder el 8 de septiembre de 2025.
Qualys, Inc.의 최고재무책임자(Chief Financial Officer) Joo Mi Kim은 2025/09/05에 2024년 8월 21일 채택된 사전 설정된 Rule 10b5-1 거래 계획에 따라 Qualys 보통주 총 844주를 매각했습니다. 세 건의 매도 거래는 주당 가중평균 매도 가격이 $133.68에서 $136.45 범위로 나타났으며, 거래 후 신고된 실질 보유 주식은 93,651주였습니다. 제출서류는 또한 2025년 8월 15일 회사의 직원 주식 구매 계획을 통해 27주의 면제된 매수를 공개하고 있습니다. Form 4는 2025년 9월 8일 위임장에 의해 서명되었습니다.
Joo Mi Kim, directrice financière (Chief Financial Officer) de Qualys, Inc., a vendu au total 844 actions ordinaires de Qualys le 05/09/2025 dans le cadre d'un plan de négociation préétabli en vertu de la Rule 10b5-1 adopté le 21 août 2024. Les trois opérations de vente montrent des prix de vente moyens pondérés par action allant de $133.68 à $136.45 et ont abouti à une participation bénéficiaire déclarée de 93 651 actions après les transactions. Le dépôt révèle également un achat exonéré de 27 actions le 15 août 2025 via le Plan d'achat d'actions pour les employés de la société. Le formulaire 4 a été signé par procuration le 8 septembre 2025.
Joo Mi Kim, Chief Financial Officer von Qualys, Inc., verkaufte am 05.09.2025 insgesamt 844 Stück Qualys-Stammaktien im Rahmen eines vorab festgelegten Rule-10b5-1-Handelsplans, der am 21. August 2024 angenommen wurde. Die drei Verkaufsaufträge weisen gewichtete Durchschnittspreise pro Aktie im Bereich von $133,68 bis $136,45 auf und führten zu einem gemeldeten wirtschaftlichen Eigentum von 93.651 Aktien nach den Transaktionen. Die Meldung gibt zudem einen befreiten Erwerb von 27 Aktien am 15. August 2025 über den Aktienkaufplan für Mitarbeiter des Unternehmens an. Das Formular 4 wurde am 8. September 2025 per Vollmacht unterzeichnet.
- Transactions executed under a Rule 10b5-1 trading plan, indicating a pre-established and documented trading arrangement
- Disclosure includes weighted-average price ranges and post-transaction beneficial ownership (93,651 shares), aiding transparency
- Additional 27 shares acquired via Employee Stock Purchase Plan disclosed as exempt under Rule 16b-3
- Insider disposed of 844 shares on 09/05/2025, reducing beneficial ownership from prior levels to 93,651 shares
- Sale price reported as ranges rather than per-lot prices; full per-price allocation is available only upon request to the Commission
Insights
TL;DR: CFO sold 844 shares under a 10b5-1 plan; post-sale holdings remain at 93,651 shares.
The transactions are routine insider sales executed under a Rule 10b5-1 plan adopted August 21, 2024, which provides an affirmative defense under insider trading rules. The filing reports three dispositions on September 5, 2025 totaling 844 shares with weighted-average sale-price ranges disclosed. Post-transaction beneficial ownership is reported as 93,651 shares, and a separate employee stock purchase on August 15, 2025 added 27 shares exempt under Rule 16b-3 provisions. From a financial perspective, these disclosures document liquidity actions by an executive but do not provide earnings or operational metrics to alter valuation models.
TL;DR: Sales are governed by a documented 10b5-1 plan; disclosure appears complete per Form 4 requirements.
The filing indicates the reporting person is the Chief Financial Officer and that the sales were made pursuant to a 10b5-1 trading plan, which is explicitly referenced in the explanations. The report includes weighted-average price ranges and notes availability of per-price sale details upon request by the Commission, satisfying common disclosure expectations. The Form 4 is signed by a power of attorney, with signature dated September 8, 2025. These elements suggest procedural compliance with Section 16 reporting and insider-trading safe-harbor practices.
Joo Mi Kim, Chief Financial Officer di Qualys, Inc., ha venduto complessivamente 844 azioni ordinarie di Qualys il 09/05/2025 nell'ambito di un piano di trading predefinito ai sensi della Rule 10b5-1 adottato il 21 agosto 2024. Le tre operazioni di vendita riportano prezzi medi ponderati per azione compresi tra $133.68 e $136.45 e hanno determinato una partecipazione beneficiaria dichiarata di 93.651 azioni a seguito delle transazioni. Il deposito segnala inoltre un acquisto esente di 27 azioni il 15 agosto 2025 attraverso il Piano di Acquisto Azioni per i Dipendenti della società. Il Modulo 4 è stato firmato per procura il 8 settembre 2025.
Joo Mi Kim, directora financiera (Chief Financial Officer) de Qualys, Inc., vendió un total de 844 acciones ordinarias de Qualys el 09/05/2025 bajo un plan de negociación preestablecido conforme a la Rule 10b5-1 adoptado el 21 de agosto de 2024. Las tres transacciones de venta muestran precios medios ponderados por acción en un rango de $133.68 a $136.45 y dieron lugar a una tenencia beneficiaria declarada de 93.651 acciones tras las operaciones. La presentación también revela una compra exenta de 27 acciones el 15 de agosto de 2025 a través del Plan de Compra de Acciones para Empleados de la compañía. El Formulario 4 fue firmado por poder el 8 de septiembre de 2025.
Qualys, Inc.의 최고재무책임자(Chief Financial Officer) Joo Mi Kim은 2025/09/05에 2024년 8월 21일 채택된 사전 설정된 Rule 10b5-1 거래 계획에 따라 Qualys 보통주 총 844주를 매각했습니다. 세 건의 매도 거래는 주당 가중평균 매도 가격이 $133.68에서 $136.45 범위로 나타났으며, 거래 후 신고된 실질 보유 주식은 93,651주였습니다. 제출서류는 또한 2025년 8월 15일 회사의 직원 주식 구매 계획을 통해 27주의 면제된 매수를 공개하고 있습니다. Form 4는 2025년 9월 8일 위임장에 의해 서명되었습니다.
Joo Mi Kim, directrice financière (Chief Financial Officer) de Qualys, Inc., a vendu au total 844 actions ordinaires de Qualys le 05/09/2025 dans le cadre d'un plan de négociation préétabli en vertu de la Rule 10b5-1 adopté le 21 août 2024. Les trois opérations de vente montrent des prix de vente moyens pondérés par action allant de $133.68 à $136.45 et ont abouti à une participation bénéficiaire déclarée de 93 651 actions après les transactions. Le dépôt révèle également un achat exonéré de 27 actions le 15 août 2025 via le Plan d'achat d'actions pour les employés de la société. Le formulaire 4 a été signé par procuration le 8 septembre 2025.
Joo Mi Kim, Chief Financial Officer von Qualys, Inc., verkaufte am 05.09.2025 insgesamt 844 Stück Qualys-Stammaktien im Rahmen eines vorab festgelegten Rule-10b5-1-Handelsplans, der am 21. August 2024 angenommen wurde. Die drei Verkaufsaufträge weisen gewichtete Durchschnittspreise pro Aktie im Bereich von $133,68 bis $136,45 auf und führten zu einem gemeldeten wirtschaftlichen Eigentum von 93.651 Aktien nach den Transaktionen. Die Meldung gibt zudem einen befreiten Erwerb von 27 Aktien am 15. August 2025 über den Aktienkaufplan für Mitarbeiter des Unternehmens an. Das Formular 4 wurde am 8. September 2025 per Vollmacht unterzeichnet.